Vivani Medical Net Income
| VANI Stock | USD 1.27 0.02 1.55% |
As of the 10th of February, Vivani Medical has the Risk Adjusted Performance of (0.02), variance of 16.26, and Coefficient Of Variation of (2,552). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vivani Medical, as well as the relationship between them.
Vivani Medical Total Revenue |
|
| Last Reported | Projected for Next Year | ||
| Net Loss | -27 M | -28.4 M | |
| Net Loss | -21.1 M | -22.2 M | |
| Net Loss | -10.3 M | -10.8 M | |
| Net Loss | (0.38) | (0.40) |
Vivani | Net Income | Build AI portfolio with Vivani Stock |
The Net Income trend for Vivani Medical offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Vivani Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Vivani Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Vivani Medical over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Vivani Medical financial statement analysis. It represents the amount of money remaining after all of Vivani Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Vivani Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vivani Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (23.49 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Vivani Net Income Regression Statistics
| Arithmetic Mean | (23,403,165) | |
| Coefficient Of Variation | (35.60) | |
| Mean Deviation | 6,995,295 | |
| Median | (23,486,000) | |
| Standard Deviation | 8,332,674 | |
| Sample Variance | 69.4T | |
| Range | 25.9M | |
| R-Value | (0.12) | |
| Mean Square Error | 73.1T | |
| R-Squared | 0.01 | |
| Significance | 0.66 | |
| Slope | (192,889) | |
| Total Sum of Squares | 1110.9T |
Vivani Net Income History
Other Fundumenentals of Vivani Medical
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Vivani Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Vivani Medical is extremely important. It helps to project a fair market value of Vivani Stock properly, considering its historical fundamentals such as Net Income. Since Vivani Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vivani Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vivani Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Biotechnology market expansion? Will Vivani introduce new products? Factors like these will boost the valuation of Vivani Medical. If investors know Vivani will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Vivani Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Vivani Medical requires distinguishing between market price and book value, where the latter reflects Vivani's accounting equity. The concept of intrinsic value - what Vivani Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Vivani Medical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Vivani Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivani Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Vivani Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Vivani Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vivani Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vivani Medical.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Vivani Medical on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Vivani Medical or generate 0.0% return on investment in Vivani Medical over 90 days. Vivani Medical is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, and Lipocine. Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet me... More
Vivani Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vivani Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vivani Medical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 18.98 | |||
| Value At Risk | (6.76) | |||
| Potential Upside | 6.99 |
Vivani Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vivani Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vivani Medical's standard deviation. In reality, there are many statistical measures that can use Vivani Medical historical prices to predict the future Vivani Medical's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.61) | |||
| Treynor Ratio | (0.29) |
Vivani Medical February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.28) | |||
| Mean Deviation | 3.05 | |||
| Coefficient Of Variation | (2,552) | |||
| Standard Deviation | 4.03 | |||
| Variance | 16.26 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.61) | |||
| Treynor Ratio | (0.29) | |||
| Maximum Drawdown | 18.98 | |||
| Value At Risk | (6.76) | |||
| Potential Upside | 6.99 | |||
| Skewness | 0.0439 | |||
| Kurtosis | 0.4868 |
Vivani Medical Backtested Returns
Vivani Medical owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0595, which indicates the firm had a -0.0595 % return per unit of risk over the last 3 months. Vivani Medical exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vivani Medical's Coefficient Of Variation of (2,552), risk adjusted performance of (0.02), and Variance of 16.26 to confirm the risk estimate we provide. The entity has a beta of 0.57, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Vivani Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Vivani Medical is expected to be smaller as well. At this point, Vivani Medical has a negative expected return of -0.24%. Please make sure to validate Vivani Medical's potential upside, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if Vivani Medical performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.12 |
Insignificant predictability
Vivani Medical has insignificant predictability. Overlapping area represents the amount of predictability between Vivani Medical time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vivani Medical price movement. The serial correlation of 0.12 indicates that less than 12.0% of current Vivani Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.12 | |
| Spearman Rank Test | 0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Vivani Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Vivani Medical reported net income of (23.49 Million). This is 106.88% lower than that of the Biotechnology sector and 109.86% lower than that of the Health Care industry. The net income for all United States stocks is 104.11% higher than that of the company.
Vivani Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vivani Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vivani Medical could also be used in its relative valuation, which is a method of valuing Vivani Medical by comparing valuation metrics of similar companies.Vivani Medical is currently under evaluation in net income category among its peers.
Vivani Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Vivani Medical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Vivani Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vivani Medical's value.| Shares | Charles Schwab Investment Management Inc | 2025-06-30 | 30 K | Panagora Asset Management Inc | 2025-06-30 | 19.5 K | Jane Street Group Llc | 2025-06-30 | 17.6 K | Susquehanna International Group, Llp | 2025-06-30 | 16.1 K | Goldman Sachs Group Inc | 2025-06-30 | 14.4 K | Ubs Group Ag | 2025-06-30 | 11.9 K | Two Sigma Securities, Llc | 2025-06-30 | 11.1 K | Sbi Securities Co Ltd | 2025-06-30 | 2 K | Headlands Technologies Llc | 2025-06-30 | 1.8 K | Vanguard Group Inc | 2025-06-30 | 1.4 M | Tanager Wealth Management Llp | 2025-06-30 | 1 M |
Vivani Fundamentals
| Return On Equity | -2.65 | ||||
| Return On Asset | -0.5 | ||||
| Current Valuation | 119.2 M | ||||
| Shares Outstanding | 81.21 M | ||||
| Shares Owned By Insiders | 35.79 % | ||||
| Shares Owned By Institutions | 4.73 % | ||||
| Number Of Shares Shorted | 214.16 K | ||||
| Price To Book | 79.10 X | ||||
| Gross Profit | 130 K | ||||
| EBITDA | (24.28 M) | ||||
| Net Income | (23.49 M) | ||||
| Cash And Equivalents | 3.45 M | ||||
| Cash Per Share | 0.28 X | ||||
| Total Debt | 19.31 M | ||||
| Current Ratio | 1.35 X | ||||
| Book Value Per Share | 0.02 X | ||||
| Cash Flow From Operations | (20.79 M) | ||||
| Short Ratio | 1.13 X | ||||
| Earnings Per Share | (0.45) X | ||||
| Target Price | 5.0 | ||||
| Number Of Employees | 37 | ||||
| Beta | 3.34 | ||||
| Market Capitalization | 102.32 M | ||||
| Total Asset | 41.56 M | ||||
| Retained Earnings | (121.92 M) | ||||
| Working Capital | 14.46 M | ||||
| Net Asset | 41.56 M |
About Vivani Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vivani Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vivani Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vivani Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is there potential for Biotechnology market expansion? Will Vivani introduce new products? Factors like these will boost the valuation of Vivani Medical. If investors know Vivani will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Vivani Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Understanding Vivani Medical requires distinguishing between market price and book value, where the latter reflects Vivani's accounting equity. The concept of intrinsic value - what Vivani Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Vivani Medical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Vivani Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivani Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Vivani Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.